Ignite Creation Date:
2025-12-25 @ 12:28 AM
Ignite Modification Date:
2026-02-26 @ 8:12 PM
Study NCT ID:
NCT01992367
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2013-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003
Sponsor:
ASLAN Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ASLAN003-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None